Abbott Labs Stock Stumbles, But Wall Street Sees a Buying Opportunity
Despite a challenging year marked by a sharp sell-off and underperformance, analysts remain overwhelmingly bullish on Abbott Laboratories, betting on a rebound driven by its diversified healthcare portfolio and earnings resilience.